Oral Antidiabetic Agents

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Drugs

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.2165/00003495-200565030-00005PMID 15669880
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metabolic and Additional Vascular Effects of Thiazolidinediones

  2012cited by this paper
• Is There a Role for α-Glucosidase Inhibitors in the Prevention of Type 2 Diabetes Mellitus?

  2012cited by this paper
• The Role of Sulphonylureas in the Management of Type 2 Diabetes Mellitus

  2012cited by this paper
• The role of gut hormones in glucose homeostasis.

  2007cited by this paper
• PPARγ and human metabolic disease

  2006cited by this paper
• Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.

  2006cited by this paper
• Vascular effects of TZDs: new implications.

  2006cited by this paper
• Glucagon-like peptide-1: from extract to agent. The Claude Bernard Lecture, 2005

  2006cited by this paper
• Meglitinide analogues: a review of clinical data focused on recent trials.

  2006cited by this paper
• Reduced incretin effect in Type 2 (non-insulin-dependent) diabetes

  2006cited by this paper
• Mechanisms linking obesity to insulin resistance and type 2 diabetes

  2006cited by this paper
• Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.

  2006cited by this paper
• Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review

  2006cited by this paper
• Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.

  2005cited by this paper
• Continuing metformin when starting insulin in patients with Type 2 diabetes: a double‐blind randomized placebo‐controlled trial

  2005cited by this paper
• Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders.

  2005cited by this paper
• Treating insulin resistance in type 2 diabetes with metformin and thiazolidinediones

  2005cited by this paper
• Effects of Angiotensin Converting Enzyme Inhibition in Patients With Stable Coronary Artery Disease: The Prevention of Events With Angiotensin Converting Enzyme Inhibition (PEACE) Trial: The PEACE Study Investigators

  2005cited by this paper
• Therapeutic roles of peroxisome proliferator-activated receptor agonists.

  2005cited by this paper
• Therapeutic strategies based on glucagon-like peptide 1.

  2004cited by this paper
• Thiazolidinediones.

  2004cited by this paper
• Metformin: its botanical background

  2004cited by this paper
• Dipeptidyl peptidase IV inhibitors for the treatment of diabetes.

  2004cited by this paper
• GUIDE study: double‐blind comparison of once‐daily gliclazide MR and glimepiride in type 2 diabetic patients

  2004cited by this paper
• Type 2 diabetes mellitus: what is the optimal treatment regimen?

  2004cited by this paper
• Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.

  2003cited by this paper
• Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?

  2003cited by this paper
• Nice timing for glitazones

  2003cited by this paper
• Sulfonylureas in the prevention of vascular complications: from UKPDS to the ADVANCE study

  2003cited by this paper
• Insulin granule dynamics in pancreatic beta cells

  2003cited by this paper
• Sulfonylureas attenuate electrocardiographic ST-segment elevation during an acute myocardial infarction in diabetics.

  2003cited by this paper
• Metformin in polycystic ovary syndrome: systematic review and meta-analysis

  2003cited by this paper
• Beta-cell rejuvenation with thiazolidinediones.

  2003cited by this paper
• Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure: A Consensus Statement From the American Heart Association and American Diabetes Association

  2003cited by this paper
• The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes

  2003cited by this paper
• Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.

  2003cited by this paper
• Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis.

  2003cited by this paper
• Is there a role for alpha-glucosidase inhibitors in the prevention of type 2 diabetes mellitus?

  2003cited by this paper
• Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial.

  2003cited by this paper
• Post-challenge hyperglycaemia is associated with premature death and macrovascular complications

  2003cited by this paper
• Peroxisome proliferator-activated receptor-gamma agonists in atherosclerosis: current evidence and future directions.

  2003cited by this paper
• Regulation of adipocytokines and insulin resistance

  2003cited by this paper
• Molecular motors

  2003cited by this paper
• Beneficial effects of metformin on haemostasis and vascular function in man.

  2003cited by this paper
• β-Cell rejuvenation with thiazolidinediones

  2003cited by this paper
• Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes.

  2002cited by this paper
• Type 2 Diabetes Mellitus in Children and Youth: A New Epidemic

  2002cited by this paper
• Diabetes and atherosclerosis: epidemiology, pathophysiology, and management.

  2002cited by this paper
• Type 2 Diabetes in Practice

  2002cited by this paper
• Metformin: An Update

  2002cited by this paper
• Pharmacological modulation of K(ATP) channels.

  2002cited by this paper
• Implementing intensive control of blood glucose concentration and blood pressure in type 2 diabetes in England: cost analysis (UKPDS 63)

  2002cited by this paper
• Combination of insulin and thiazolidinedione therapy in massively obese patients with Type 2 diabetes

  2002cited by this paper
• Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.

  2002cited by this paper
• Diabetes Therapeutics News

  2002cited by this paper
• Oral antihyperglycemic therapy for type 2 diabetes: scientific review.

  2002cited by this paper
• Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes.

  2002cited by this paper
• Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

  2002cited by this paper
• Efficacy, effectiveness and safety of sulphonylurea–metformin combination therapy in patients with type 2 diabetes

  2002cited by this paper
• PPARγ: a Nuclear Regulator of Metabolism, Differentiation, and Cell Growth*

  2001cited by this paper
• Cardiovascular risk reduction in diabetes: underemphasised and overdue. Messages from major trials.

  2001cited by this paper
• Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of rosiglitazone.

  2001cited by this paper
• Pharmacological modulation of KATP channels

  2001cited by this paper
• Role of AMP-activated protein kinase in mechanism of metformin action.

  2001cited by this paper
• Insulinotropic meglitinide analogues.

  2001cited by this paper
• Insulin resistance and cardiovascular disease.

  2001cited by this paper
• Combination therapies with insulin in type 2 diabetes.

  2001cited by this paper
• PPARgamma : a nuclear regulator of metabolism, differentiation, and cell growth.

  2001cited by this paper
• Nonhypoglycemic Effects of Thiazolidinediones

  2001cited by this paper
• Transforming Growth Factor-α Prevents Detachment-induced Inhibition of c-Src Kinase Activity, Bcl-XLDown-regulation, and Apoptosis of Intestinal Epithelial Cells*

  2001cited by this paper
• Optimisation of the Management of Patients with Coronary Heart Disease and Type 2 Diabetes Mellitus

  2001cited by this paper
• Plasma glucose levels throughout the day and HbA(1c) interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic control.

  2001cited by this paper
• Thiazolidinediones for type 2 diabetes. New agents reduce insulin resistance but need long term clinical trials.

  2000cited by this paper
• Thiazolidinediones: an update.

  2000cited by this paper
• Antidiabetic drugs present and future: will improving insulin resistance benefit cardiovascular risk in type 2 diabetes mellitus?

  2000cited by this paper
• Controlling glucose and blood pressure in type 2 diabetes

  2000cited by this paper
• Metformin and lactic acidosis in diabetic humans

  2000cited by this paper
• Antidiabetic Drugs Present and Future

  2000cited by this paper
• Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

  2000cited by this paper
• Desensitization of sulphonylurea- and nutrient-induced insulin secretion following prolonged treatment with glibenclamide.

  2000cited by this paper
• Thiazolidinediones for type 2 diabetes

  2000cited by this paper
• Meglitinide Analogues in the Treatment of Type 2 Diabetes Mellitus

  2000cited by this paper
• Insulin resistance and cardiovascular disease.

  2000cited by this paper
• A Risk-Benefit Assessment of Metformin in Type 2 Diabetes Mellitus

  1999cited by this paper
• AMP-activated protein kinase, a metabolic master switch: possible roles in Type 2 diabetes.

  1999cited by this paper
• AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes.

  1999cited by this paper
• Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

  1999cited by this paper
• Comparison of Bedtime Insulin Regimens in Patients with Type 2 Diabetes Mellitus

  1999cited by this paper
• A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)

  1999cited by this paper
• Thiazolidinediones: a new class of antidiabetic drugs

  1999cited by this paper
• Pharmacologic Therapy for Type 2 Diabetes Mellitus

  1999cited by this paper
• A desktop guide to Type 2 diabetes mellitus. European Diabetes Policy Group 1999.

  1999cited by this paper
• ATP-sensitive K+ channels and insulin secretion: their role in health and disease

  1999cited by this paper
• Closing the audit loop with the Diabetes Clinic Satisfaction Questionnaire (DCSQ) : reducing sources of dissatisfaction and increasing clinician sensitivity to patients' views

  1999cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

  1998cited by this paper
• Metformin: A review of its metabolic effects

  1998cited by this paper
• Contraindications to Metformin Therapy in Patients With NIDDM

  1997cited by this paper

• Green-fabricated zinc sulfide nanoparticles with dual antidiabetic and anticancer efficacy

  2026cites this paper
• Design and synthesis of new bis(α-aminophosphonates) via ultrasound-driven nano-BF 3 ·SiO 2 catalysis targeting α-amylase inhibition: In silico ADME and molecular docking study

  2026cites this paper
• An in vitro investigation of diet-influenced gut bacterial metabolites on the onset of Type 2 Diabetes Mellitus using a multi-cellular human primary islet model

  2026cites this paper
• Phytochemical profiling and anti-postprandial hyperglycemia potential of Opuntia ficus-indica thorn cladodes from Al Zawia- Libya.

  2026cites this paper
• Antidiabetic Potential of Lantana camara Flower Extract: Phytochemical Analysis and Enzyme Inhibition Studies

  2025cites this paper
• A Data Mining Approach on Polypharmacy and Drug-drug Interactions of Common Diabetes Medications.

  2025cites this paper
• Flavonoids and their metal complexes as potential agents for diabetes mellitus with future perspectives

  2025cites this paper
• Efficacy and safety of chiglitazar add‐on to metformin in type 2 diabetes mellitus (RECAM study)

  2025cites this paper
• Revolutionizing diabetes treatment: computational insights into 4-hydroxy isoleucine derivatives and advanced molecular screening for antidiabetic compounds

  2025cites this paper
• Evaluation of Potential Anti-Inflammatory Activities in Crude, Purified, and Fractionated Extracts of Rosmarinic Acid and Eupatorin from Orthosiphon aristatus (Blume) Miq.

  2025cites this paper
• Safety of concomitant use of oral anticoagulants and antidiabetic drugs: a systematic review of observational studies

  2025cites this paper
• Comprehensive Review and Perspective on Fructose 1,6-Bisphosphatase Inhibitors for the Management of Type 2 Diabetes Mellitus

  2025cites this paper
• Drug repurposing: Identification and X-ray crystallographic analyses of US-FDA approved drugs against carbonic anhydrase-II.

  2025cites this paper
• Novel pyrido[2,3-d]pyrimidines linked to benzyloxy phenyl and benzyloxy triazole hybrids as alpha-glucosidase inhibitors: synthesis, in vitro evaluation, and in silico studies

  2025cites this paper
• Unlocking the dual healing powers of plant-based metallic nanoparticles: managing diabetes and tackling male infertility challenges

  2025influential citation
• Identification of Selective α-Glucosidase Inhibitors via Virtual Screening with Machine Learning

  2025cites this paper
• Deoxynojirimycin derivatives as potent α-glucosidase inhibitors: in silico ADMET evaluation, molecular dynamics and in vitro validation studies.

  2025cites this paper
• Mechanistic insights into therapeutic potential of Centella asiatica (L.) Urb.in diabetes mellitus and its chronic health complexities: from botany, medicinal chemistry to clinical trials approach

  2025cites this paper
• Effect of β-Caryophyllene on PPAR-γ, NF-κB, and CNR2: Implications for Gut–Brain Axis Communication in a Murine Model of Diet-Induced Obesity

  2025cites this paper
• Synthesis and novel structural hybrid analogs of oxindole derivatives bearing piperidine ring, their antidiabetics II activity and molecular docking Study

  2025cites this paper
• Valorization of Araucaria Excelsa Extract for Synthesis of Silver Nanoparticles and their Potential Anticancer Properties

  2025cites this paper
• Real-time continuous glucose monitoring vs self-monitoring of blood glucose in distinct multi-ethnic cohorts of patients living with insulin-treated type 2 diabetes in the United States: A cost-utility analysis from a Medicare perspective.

  2025cites this paper
• Gas Chromatography-Mass Spectroscopic Profile, In vitro Antidiabetic and Radical Scavenging Potentials of Polyalthia longifolia leaf phenolic extract

  2025cites this paper
• α-Glycosidase activity of novel coumarin–triazole–coumarin dyads

  2025cites this paper
• Identification of novel triazolopyrimidines as potent α-glucosidase inhibitor through design, synthesis, biological evaluations, and computational analysis

  2025cites this paper
• Tear-based glucose monitoring: A non-invasive approach to diabetes control in resource-limited settings.

  2025cites this paper
• Exploration of a Novel Indole/Pyrazole Scaffold as a Promising Dual α-Glucosidase and α-Amylase Inhibitor: an In Vitro, In Vivo and In Silico Approach Toward Antidiabetic Drug Design

  2025cites this paper
• Computational Insights into Aldose Reductase Inhibition by Soy Isoflavones: A Pathway To Diabetes Mitigation

  2025cites this paper
• Matricaria pubescens (DESF.) SCH. essential oils and their potential to inhibit several critical enzymes linked to type II diabetes and Alzheimer’s disease and antimicrobial activity

  2025influential citation
• Protein–ligand molecular dynamics simulation (PL-MDS), ADMET analyses, and bioactivity studies of phytochemicals from Aloe Vera: an In-Silico novel antidiabetics drug discovery effort

  2025cites this paper
• Polydatin from Polygoni Cuspidati Rhizoma et Radix regulates glucolipid metabolism in the liver of diabetic rats: Multiscale analysis of network pharmacology and multiomics.

  2024cites this paper
• Synthesis of novel chromenyl phosphonates via nano-ZnO-catalyzed microwave method: Exploring potential anti-diabetic agents through molecular docking, ADMET analysis, and α-amylase inhibition

  2024cites this paper
• A Convenient Synthesis of Short α-/β-Mixed Peptides as Potential α-Amylase Inhibitors

  2024influential citation
• Pulmonary and respiratory health antioxidants and nutraceuticals

  2024cites this paper
• Bio-fabrication of zinc oxide nanoparticles from Brassica juncea (L.) Czern extract: Biological activity and DNA binding capability

  2024cites this paper
• Seaweeds as Nutraceutical Elements and Drugs for Diabetes Mellitus: Future Perspectives

  2024cites this paper
• A comprehensive in-vitro/in-vivo screening toolbox for the elucidation of glucose homeostasis modulating properties of plant extracts (from roots) and its bioactives

  2024cites this paper
• Design and Development of a Non-invasive Opto-Electronic Sensor for Blood Glucose Monitoring Using a Visible Light Source

  2024cites this paper
• Potential Antihyperglycemic Effects of Adzuki (Vigna angularis) Polyphenols on Mice and Caco-2 Cells

  2024cites this paper
• Hypoglycemic Drugs in Patients with Diabetes Mellitus and Heart Failure: A Narrative Review

  2024cites this paper
• Synthesis of novel oxadiazole derivatives: DFT calculations, molecular docking studies, and in vitro, in vivo evaluation of antidiabetic activity using Drosophila melanogaster model

  2024cites this paper
• Eco-friendly Ag-CuO nanoparticles for antidiabetic, antimicrobial, anti-cancer, platelet aggregation inducing, antioxidant and photocatalytic applications

  2024cites this paper
• Catechin inhibits glycosidases, ameliorates glucose uptake and Glut-4 expression in 3T3-L1 adipocytes.

  2024cites this paper
• Synthesis of chalconoyl pregnenolones as antimicrobial, antidiabetic and antioxidant agents

  2024cites this paper
• Bioassay-guided isolation and characterisation of α-glucosidase inhibitors from Sanghuangporus baumii

  2024cites this paper
• Effects of Pharmaceutical Substances with Obesogenic Activity on Male Reproductive Health

  2024cites this paper
• Bioactive Potential of Baby Corn Silk: In-Vitro Evaluation of Antioxidant, Antimicrobial, Anti-diabetic, and Anti-gout Activities

  2024cites this paper
• Benchmarking the medication efficiency and technological progress of diabetes drugs

  2024cites this paper
• HPLC-Based Metabolomic Analysis and Characterization of Amaranthus cruentus Leaf and Inflorescence Extracts for Their Antidiabetic and Antihypertensive Potential

  2024influential citation
• Cerium-Based Metal–Organic Framework Nanocrystals for Colorimetric Screening of α-Glucosidase Inhibitors

  2024cites this paper
• Diphenolic boldine, an aporphine alkaloid: inhibitory effect evaluation on α-glucosidase by molecular dynamics integrating enzyme kinetics

  2024cites this paper
• Revealing metabolic and biochemical variations via 1H NMR metabolomics in streptozotocin-nicotinamide-induced diabetic rats treated with metformin.

  2024cites this paper
• Detailed investigation on the polyphenols from four Dendrobium species against α-glucosidase: An integrated in vitro and in silico approach

  2024cites this paper
• Antidiabetic effects and mechanisms of Cyclocarya paliurus leaf flavonoids via PIK3CA

  2024cites this paper
• Anti-Aging Drugs and the Related Signal Pathways

  2024cites this paper
• The Role of the Gut Microbiome in the Development and Progression of Type 2 Diabetes and Liver Disease.

  2024cites this paper
• Exploring dihydropyrimidone derivatives as modulators of carbohydrate catabolic enzyme to mitigate diabetes

  2024cites this paper
• African Under-Utilized Medicinal Leafy Vegetables Studied by Microtiter Plate Assays and High-Performance Thin-Layer Chromatography–Planar Assays

  2024cites this paper
• Loxenatide Alleviates High Glucose-Induced Pancreatic β-Cell Senescence via Regulating the PERK/eIF2α Pathway

  2024cites this paper
• Dietary intake of cluster bean decrease the complication associated with covid 19 infected patients

  2024cites this paper
• Antidiabetic and Antihyperlipidemic Activity of Ethanolic Extract of Mentha viridis in Alloxan Induced Diabetic Rats

  2024cites this paper
• The In Vitro Inhibitory Activity of Pacaya Palm Rachis versus Dipeptidyl Peptidase-IV, Angiotensin-Converting Enzyme, α-Glucosidase and α-Amylase

  2024cites this paper
• Virtual screening, molecular docking, and molecular dynamics simulation studies on the hypoglycemic function of oat peptides.

  2024cites this paper
• Synthesis, Spectroscopic Analysis and Antidiabetic Properties of Copper (II) Complex of Mangifera indica Leaf Crude Extract

  2023cites this paper
• Designing Potent α-Glucosidase Inhibitors: A Synthesis and QSAR Modeling Approach for Biscoumarin Derivatives

  2023cites this paper
• Abnormalities of glucose and lipid metabolism in myocardial ischemia-reperfusion injury.

  2023cites this paper
• Nanocrystal Engineering: Unraveling Bioactivities and Augmented Photocatalytic Degradation of ZnO and Cr-Doped ZnO via Green and Chemical Synthesis Routes

  2023cites this paper
• Intestinal glucose excretion: A potential mechanism for glycemic control.

  2023cites this paper
• Longitudinal Assessment of Multimorbidity Medication Patterns among Smokers in the COPDGene Cohort

  2023influential citation
• Anti-diabetics and the Prevention of Dementia: A Systematic Review

  2023cites this paper
• Procyanidin Dimer from the Stem Bark of Moringa oleifera (Lam.) Attenuates Insulin Resistance in Rats

  2023cites this paper
• Smart Responsive Microneedles for Controlled Drug Delivery

  2023cites this paper
• Synthesis and bioactivity assessment of Coccinia grandis L. extract encapsulated alginate nanoparticles as an antidiabetic drug lead

  2023cites this paper
• Cannabidiol Mitigates Lipopolysaccharide-Induced Pancreatic Pathology: A Promising Therapeutic Strategy

  2023cites this paper
• α-Glucosidase Inhibitors from Two Mangrove-Derived Actinomycetes

  2023cites this paper
• Lawsonia inermis flower aqueous extract expressed better anti-alpha-glucosidase and anti-acetylcholinesterase activity and their molecular dynamics

  2023cites this paper
• Pharmacologic Heterogeneity and Risk of Severe Hypoglycemia with Concomitant Use of Sulfonylureas and DPP‐4 Inhibitors: Population‐Based Cohort Study

  2023cites this paper
• Identification of potential anti-hyperglycemic compounds in Cordyceps militaris ethyl acetate extract: in vitro and in silico studies

  2023cites this paper
• Fecal microbiota transplantation reverses insulin resistance in type 2 diabetes: A randomized, controlled, prospective study

  2023cites this paper
• Synthesis, in silico, in vitro and in vivo studies of novel natural-based arylidenes curcumin as potential glycohydrolase digestive enzymes inhibitors

  2023cites this paper
• Design, synthesis and anti-hyperglycemic assessments of novel 5-benzylidenethiazolidine-2,4-dione derivatives as PPAR-γ agonist

  2023cites this paper
• Ultrasound mediated nano ZnO catalyzed synthesis of new α-aminophosphonates as potential anti-diabetic agents; an in silico ADMET, molecular docking study, α-amylase and α-glucosidase inhibitory activity

  2023cites this paper
• Characterization of Green and Yellow Papaya (Carica papaya) for Anti-Diabetic Activity in Liver and Myoblast Cells and Wound-Healing Activity in Fibroblast Cells

  2023cites this paper
• Comparative Efficacy of Metformin and Glimepiride in Modulating Pharmacological Network to Increase BDNF Levels and Benefit Type 2 Diabetes-Related Cognitive Impairment

  2023cites this paper
• Protective effects and mechanisms of opuntia polysaccharide in animal models of diabetes mellitus: A systematic review and meta-analysis.

  2023cites this paper
• Pancreatic beta cell regenerative potential of Zanthoxylum chalybeum Engl. Aqueous stem bark extract.

  2023cites this paper
• 2,3-Dihydrosorbicillin and Chrysopanol Stimulate Insulin Secretion in INS-1 Cells.

  2023cites this paper
• Inhibitory Mechanism of Quercimeritrin as a Novel α-Glucosidase Selective Inhibitor

  2023cites this paper
• Pharmacokinetics and tissue distribution of Ramulus Mori (Sangzhi) alkaloids in rats and its effects on liver enzyme activity

  2023cites this paper
• Effect of grain/bran crude extract from Fagopyrum tataricum on hypoglycemic activity of type 2 diabetes mice and study on molecular mechanism of treatment

  2023cites this paper
• Lifespan-extending interventions induce consistent patterns of fatty acid oxidation in mouse livers

  2023cites this paper
• Regeneration of Pancreatic Beta Cells by Modulation of Molecular Targets Using Plant-Derived Compounds: Pharmacological Mechanisms and Clinical Potential

  2023cites this paper
• In-vitro high-throughput library screening—Kinetics and molecular docking studies of potent inhibitors of α-glucosidase

  2023cites this paper
• Comprehensive micropollutant characterization of wastewater during Covid-19 crisis in 2020: Suspect screening and environmental risk prioritization strategy

  2023cites this paper
• Synthesis and potential antidiabetic and lipid-lowering activities of putative asperidine B and its desmethyl analogue.

  2023cites this paper
• Pharmacognostic Evaluation and Anti-Diabetic Activity of Ethanol Extract of Triumfetta cordifolia A. Rich (Tiliaceae) Leaves

  2022cites this paper
• Chemical compositions, in vitro assessments of antioxidant and antidiabetic potentials of Cyanomentra vogelii Hook. F.

  2022cites this paper
• Multiclass target analysis of contaminants of emerging concern including transformation products, soil bioavailability assessment and retrospective screening as tools to evaluate risks associated with reclaimed water reuse.

  2022cites this paper
• Current and future approaches for in vitro hit discovery in diabetes mellitus.

  2022cites this paper
• Pitfalls in methods to study colocalization of nanoparticles in mouse macrophage lysosomes

  2022cites this paper